InvestSMART

Artrya Limited (ASX: AYA) - Announcements

Current share price for AYA : $3.190 0.25 (7.27%)+

ASX company news and announcements for Artrya Limited (AYA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Artrya Limited (AYA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Artrya Limited (AYA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Artrya Limited (AYA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$522 Results of Annual General Meeting 13 Nov 2026 6:23PM $3.190 $3.190 fallen by 0%
$522 AGM Chairmans Address and CEO Presentation 13 Nov 2026 2:04PM $3.270 $3.190 fallen by 2.45%
$522 Five Yr Agreement with HonorHealth Expands US Momentum 13 Nov 2026 8:50AM $3.440 $3.190 fallen by 7.27%
$522 Ceasing to be a substantial holder 10 Nov 2026 6:24PM $3.660 $3.190 fallen by 12.84%
$522 Becoming a substantial holder 9 Nov 2026 5:51PM $3.480 $3.190 fallen by 8.33%
$522 Ceasing to be a substantial holder 6 Nov 2026 1:42PM $3.660 $3.190 fallen by 12.84%
$522 Artrya 2026 Annual General Meeting - Webinar Details 6 Nov 2026 8:30AM $3.500 $3.190 fallen by 8.86%
$522 Becoming a substantial holder 27 Oct 2026 6:47PM $2.600 $3.190 risen by 22.69%
$522 Ceasing to be a substantial holder 26 Oct 2026 5:28PM $2.460 $3.190 risen by 29.67%
$522 September Quarterly Activities Report and Appendix 4C 26 Oct 2026 8:40AM $2.450 $3.190 risen by 30.20%
$522 Becoming a substantial holder 23 Oct 2026 8:02PM $2.450 $3.190 risen by 30.20%
$522 Artrya September Quarter - Report Timing & Investor Webinar 22 Oct 2026 9:28AM $2.650 $3.190 risen by 20.38%
$522 Notice of Annual General Meeting/Proxy Form 14 Oct 2026 5:23PM $2.880 $3.190 risen by 10.76%
$522 Application for quotation of securities - AYA 6 Oct 2026 6:15PM $3.150 $3.190 risen by 1.27%
$522 Issue of Shares on Exercise of Securities & Cleansing Notice 6 Oct 2026 6:12PM $3.150 $3.190 risen by 1.27%
$522 Huntsville Hospital Health System Commercial Agreement 2 Oct 2026 8:32AM $3.430 $3.190 fallen by 7%
$522 Ceasing to be a substantial holder 30 Sep 2026 6:08PM $3.560 $3.190 fallen by 10.39%
$522 Change in substantial holding 30 Sep 2026 5:05PM $3.560 $3.190 fallen by 10.39%
$522 Becoming a substantial holder 29 Sep 2026 6:20PM $3.540 $3.190 fallen by 9.89%
$522 Becoming a substantial holder 24 Sep 2026 8:19AM $3.870 $3.190 fallen by 17.57%
$522 Change in substantial holding 22 Sep 2026 5:03PM $3.820 $3.190 fallen by 16.49%
$522 Ceasing to be a substantial holder from WAM/WAA/WMI/WAX 18 Sep 2026 6:20PM $3.940 $3.190 fallen by 19.04%
$522 Application for quotation of securities - AYA 16 Sep 2026 4:57PM $3.280 $3.190 fallen by 2.74%
$522 Issue of Shares on Exercise of Securities & Cleansing Notice 16 Sep 2026 4:54PM $3.280 $3.190 fallen by 2.74%
$522 Application for quotation of securities - AYA 14 Sep 2026 4:53PM $3.220 $3.190 fallen by 0.93%

1 - 25 of 545 results

Page 1 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.